Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 10Terminated 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Lymphoma 9Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myeloid, Acute 7Leukemia 6Multiple Myeloma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Hodgkin Disease 4Myelodysplastic Syndromes 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Sarcoma 2Retinoblastoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Solid Tumors 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Recurrence 1Primary Myelofibrosis 1Polycythemia Vera 1

Interventions

Magnetic Resonance Spectroscopy 4Temozolomide 3Radiotherapy 2vocimagene amiretrorepvec 1gallium Ga 68 dotatate 1cabazitaxel 1Radiation 1Proton Magnetic Resonance Spectroscopy 1Procarbazine 1OKN 007 1Nivolumab 1Magnetic Resonance Imaging 1Isotretinoin 1Irinotecan 1Gadolinium DTPA 1Filgrastim 1Equipment and Supplies 1DNA 1Carboplatin 1Biopsy 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Oligodendroglioma × Filgrastim × Clear all
NCT00006263 2015-08-05

Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma

NYU Langone Health

Phase 2 Withdrawn
CNSSarcoma

Astrocytoma, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡